US stock · Healthcare sector · Medical Instruments & Supplies
Company Logo

AptarGroup, Inc.

ATRNYSE

106.54

USD
+2.09
(+2.00%)
Market Open
31.66P/E
24Forward P/E
1.22P/E to S&P500
6.986BMarket CAP
1.46%Div Yield
Upcoming Earnings
28 Jul
Shares Short
5/13/22
1.06M
Short % of Float
1.81%
Short % of Shares Outs.
1.61%
% Held by Insiders
0.51%
% Held by Institutions
92.02%
Beta
0.64
PEG Ratio
3.20
52w. high/low
149.15/97.19
Avg. Daily Volume
0.28M
Return %
Stock
S&P 500
1 year
(29.56)
(6.01)
3 years
(7.82)
39.24
5 years
23.84
63.25
Scale: |
High
Low
44.75
28.73
46.19
23.74
38.96
24.95
48.45
34.46
54.66
41.98
55.49
45.19
67.86
48.14
68.78
55.59
75.96
60.73
81.50
66.33
90.79
71.44
112.31
79.97
126.20
88.26
137.36
79.84
158.97
112.37
124.14
97.19
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
22.96
27.50
30.53
27.23
30.84
35.12
35.11
38.13
39.96
37.02
37.11
39.55
44.28
44.98
45.47
50.10
50.10
Earnings per share
1.48
2.06
2.26
1.84
2.58
2.76
2.45
2.60
2.95
3.19
3.27
3.52
3.12
3.81
3.32
3.79
3.39
FCF per share
1.22
1.95
0.96
2.19
2.12
1.22
2.11
2.02
2.35
2.80
3.12
2.69
1.63
4.21
4.94
0.86
1.01
Dividends per share
0.42
0.50
0.56
0.60
0.66
0.80
0.88
1.00
1.09
1.14
1.22
1.28
1.32
1.42
1.44
1.53
1.52
CAPEX per share
1.61
2.02
3.02
2.15
1.77
2.70
2.62
2.30
2.49
2.39
2.09
2.51
3.39
3.89
3.91
4.78
4.82
Book Value per sh.
13.57
16.26
16.67
18.52
18.99
19.38
20.78
22.39
16.97
18.37
18.69
21.01
22.78
24.73
28.72
30.57
30.01
Comm.Shares outs.
70
69
68
68
67
67
66
66
65
63
63
62
62
64
64
64
66
Avg. annual P/E ratio
18.1
17.8
16.8
18.1
16.2
17.9
20.9
22.2
21.8
21.0
23.1
23.3
30.8
29.4
34.0
35.6
31.7
P/E to S&P500
1.0
1.0
0.8
0.3
0.8
1.1
1.4
1.3
1.2
1.0
1.0
1.0
1.2
1.2
0.9
1.2
1.2
Avg. annual div. yield
1.6%
1.4%
1.5%
1.8%
1.6%
1.6%
1.7%
1.7%
1.7%
1.7%
1.6%
1.6%
1.4%
1.3%
1.3%
1.1%
1.2%
Revenue (m)
1,601
1,892
2,072
1,842
2,077
2,337
2,331
2,520
2,598
2,317
2,331
2,469
2,765
2,860
2,929
3,227
3,295
Operating margin
10.1%
11.1%
11.0%
11.2%
12.9%
12.3%
11.1%
11.3%
11.8%
14.0%
13.3%
13.0%
10.4%
13.0%
11.6%
10.8%
10.7%
Depreciation (m)
115
123
131
133
133
134
137
150
152
139
155
153
172
195
220
235
236
Net profit (m)
103
142
153
125
173
184
163
172
192
199
206
220
195
242
214
244
223
Income tax rate
30.6%
30.2%
30.5%
32.3%
31.8%
33.2%
32.7%
35.0%
33.1%
32.3%
26.7%
25.4%
26.8%
29.2%
28.9%
24.3%
27.8%
Net profit margin
6.4%
7.5%
7.4%
6.8%
8.4%
7.9%
7.0%
6.8%
7.4%
8.6%
8.8%
8.9%
7.0%
8.5%
7.3%
7.6%
6.8%
Working capital (m)
363
438
485
526
641
625
584
656
609
883
727
1,142
642
608
589
376
781
Long-term debt (m)
169
147
227
210
259
255
350
352
587
761
772
1,191
1,126
1,085
1,107
955
1,295
Equity (m)
946
1,119
1,131
1,253
1,279
1,290
1,380
1,480
1,103
1,149
1,174
1,312
1,423
1,572
1,850
1,969
1,983
ROIC
8.6%
10.5%
11.4%
8.8%
11.4%
11.9%
9.4%
9.5%
11.2%
11.0%
11.2%
9.6%
8.1%
9.3%
7.4%
8.5%
6.9%
Return on capital
9.3%
10.6%
13.1%
10.3%
13.2%
13.5%
11.2%
11.4%
12.6%
13.5%
12.1%
10.7%
8.8%
10.6%
8.4%
8.5%
7.7%
Return on equity
10.9%
12.7%
13.6%
9.9%
13.6%
14.2%
11.8%
11.6%
17.4%
17.3%
17.5%
16.8%
13.7%
15.4%
11.6%
12.4%
11.2%
Plowback ratio
71.5%
75.7%
75.2%
67.4%
74.4%
71.0%
64.1%
61.5%
62.9%
64.3%
62.7%
63.7%
57.7%
62.8%
56.7%
59.6%
55.1%
Div.&Repurch./FCF
79.2%
68.3%
146.5%
47.3%
91.9%
191.6%
98.9%
138.8%
269.7%
48.6%
106.3%
143.6%
141.5%
66.1%
29.1%
318.3%
250.2%
Capital Structure
29 Apr · 2022 | Q1
All numbers in millions
Total liabilities
$ 2,409
Total assets
$ 4,407
Long-term debt
$ 1,295
Cash and equiv.
$ 356
Goodwill
$ 962
Retained earnings
$ - -
Common stock
66
Enterprise Value
$ 7,925
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
242
300
124
Receivables
558
567
671
Inventory
376
379
441
Other
115
181
3
Current assets
1,291
1,369
1,358
Acc. Payable
193
244
285
Debt due
110
118
290
Other
380
419
408
Current liabilities
683
780
982
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
10.17%
7.00%
3.88%
Cash flow
(82.55)%
14.92%
9.10%
Earnings
14.04%
3.82%
5.18%
Dividends
6.31%
5.40%
6.04%
Book value
6.43%
10.77%
4.77%
Insider Trading
Type
Shares
Date
Kramvis Andreas
Award
1,302
05/04/22
Fotiades George L
Award
1,475
05/04/22
Owens B Craig
Award
1,302
05/04/22
Montiel Maritza Gomez
Award
1,302
05/04/22
Kampouri Monnas Giovanna
Award
1,302
05/04/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
722
699
759
749
2,929
2021
777
811
825
814
3,227
2022
845
- -
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.86
0.65
0.99
0.83
3.32
2021
1.30
0.86
0.73
0.89
3.79
2022
0.95
- -
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.36
0.36
0.36
0.36
1.44
2021
0.36
0.39
0.39
0.39
1.53
2022
0.38
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
CEO:
Mr. Stephan Tanda
Full-time employees:
13,000
City:
Crystal Lake
Address:
265 Exchange Dr Ste 100
IPO:
Apr 23, 1993
Website:
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.